These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 3933404

  • 21. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL.
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The mechanism of factor VIII inactivation by human antibodies. II. The effect of factor VIII R: antigen on the rate of interaction.
    Lazarchick J.
    Ann Clin Lab Sci; 1985 Nov; 15(1):76-82. PubMed ID: 3918497
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE, Arena AA.
    Biochemistry; 1998 Sep 29; 37(39):13526-35. PubMed ID: 9753438
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME, Gordon HJ, McKee PA.
    Biochemistry; 1983 Mar 15; 22(6):1437-44. PubMed ID: 6188490
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.
    Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS.
    Blood; 1984 Feb 15; 63(2):486-9. PubMed ID: 6419799
    [Abstract] [Full Text] [Related]

  • 30. Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopes.
    Fulcher CA, Roberts JR, Holland LZ, Zimmerman TS.
    J Clin Invest; 1985 Jul 15; 76(1):117-24. PubMed ID: 2410456
    [Abstract] [Full Text] [Related]

  • 31. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.
    Eaton D, Rodriguez H, Vehar GA.
    Biochemistry; 1986 Jan 28; 25(2):505-12. PubMed ID: 3082357
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Dissociation of human factor VIII and recombination of the fragments VIII-C and VIII-AG].
    Tran TH, Bounameaux H, Marbet GA, Duckert F.
    Schweiz Med Wochenschr; 1979 Jul 14; 109(28):1029-34. PubMed ID: 462170
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.
    Fulcher CA, Zimmerman TS.
    Proc Natl Acad Sci U S A; 1982 Mar 14; 79(5):1648-52. PubMed ID: 6803246
    [Abstract] [Full Text] [Related]

  • 39. The estimation of the number of binding sites for antibody on antigen molecules with reference to factor VIII and its antibody.
    Pool J, Biggs R, Miller RG.
    Thromb Haemost; 1976 Apr 30; 35(2):274-88. PubMed ID: 989628
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.